Inflammatory and endothelial markers in women with polycystic ovary syndrome

被引:129
|
作者
Diamanti-Kandarakis, E.
Alexandraki, K.
Piperi, C.
Protogerou, A.
Katsikis, I.
Paterakis, T.
Lekakis, J.
Panidis, D.
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Laiko Hosp, Dept Med 1,Div Endocrinol, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Biol Chem Lab, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Vasc Lab, Athens, Greece
[4] Aristotle Univ Thessaloniki, Sch Med, Div Endocrinol & Human Reprod, Dept Obstet & Gynecol 2, GR-54006 Thessaloniki, Greece
关键词
D O I
10.1111/j.1365-2362.2006.01712.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Women with polycystic ovary syndrome (PCOS) carry a pattern of cardiovascular risk factors. Endothelial dysfunction and chronic inflammation are early findings in the atherosclerotic process. The purpose of the study was to investigate the coexistence of active inflammation markers and endothelial dysfunction in young women with PCOS, and their relationship with metabolic and hormonal abnormalities of the syndrome. Materials and methods Twenty-five young women with PCOS and 25 controls of similar age and body mass index (BMI) were studied. Endothelial function was assessed by flow-mediated dilatation (FMD) on the brachial artery and smooth muscle cells injury was excluded by nitrate-induced dilatation (NID). Plasma levels of endothelin-1 (ET-1), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and high sensitivity C-reactive protein (hsCRP) were measured. Hormonal and metabolic profiles were determined in both groups. Results Flow-mediated dilatation (FMD) was statistically lower in PCOS (P < 0.001), whereas nitrate-induced dilatation (NID) was similar within the two groups. Polycystic ovary syndrome (PCOS) had statistically higher levels of ET-1 (P = 0.03), sICAM-1 (P = 0.01), sVCAM-1 (P = 0.02) and hsCRP (P = 0.01). Furthermore FMD was statistically higher in PCOS population with hsCRP 1 mg L-1 when compared with PCOS population with hsCRP > 1 mg L-1 (P = 0.02). Flow-mediated dilatation (FMD) was negatively related to hsCRP (r = -0.512, P = 0.015); ET-1 was positively related to free androgen index (r = 0.27, P = 0.05) and negatively to sex hormone-binding globulin (r = -0.465, P = 0.022); sVCAM-1 was positively related to total testosterone (r = 0.431, P = 0.036); hsCRP was positively related to BMI (r = 0.647, P = 0.001), and negatively related to FMD (r = -0.512, P = 0.015), quantitative insulin sensitivity check index (QUICKI) (r = -0.499, P = 0.018), and MATSUDA index (r = -0.445, P = 0.038). Conclusions The present study demonstrates that endothelial dysfunction coexists and is influenced by the presence of increased serum levels of inflammation and endothelial activation markers in young women with PCOS. These parameters appear to be interrelated with hyperandrogenaemia in this insulin-resistant population.
引用
收藏
页码:691 / 697
页数:7
相关论文
共 50 条
  • [1] Inflammatory Markers in Women with Polycystic Ovary Syndrome
    Rudnicka, E.
    Kunicki, M.
    Suchta, K.
    Machura, P.
    Grymowicz, M.
    Smolarczyk, R.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [2] Inflammatory markers in women with polycystic ovary syndrome
    Ardawi, Mohamed S.
    Rouzi, Abdulrahim A.
    [J]. REPRODUCTIVE SCIENCES, 2008, 15 (02) : 167A - 167A
  • [3] Inflammatory markers in women with polycystic ovary syndrome.
    Ardawi, M. M.
    Rouzi, A. A.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S185 - S186
  • [4] Selected markers of endothelial dysfunction in women with polycystic ovary syndrome
    Foltyn, Wanda
    Strzelczyk, Janusz
    Marek, Bogan
    Kajdaniuk, Dariusz
    Sieminska, Lucyna
    Zemczak, Anna
    Blicharz-Dorniak, Jolanta
    Kos-Kudla, Beata
    [J]. ENDOKRYNOLOGIA POLSKA, 2011, 62 (03) : 243 - 248
  • [5] Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome
    Boshku, Aleksandra Atanasova
    Panova, Daniela Ivanova
    Ivanovska, Beti Zafirova
    [J]. VOJNOSANITETSKI PREGLED, 2019, 76 (07) : 703 - 709
  • [6] Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome
    Sathyapalan, Thozhukat
    Javed, Zeeshan
    Kilpatrick, Eric S.
    Coady, Anne-Marie
    Atkin, Stephen L.
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 384 - 387
  • [7] Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome
    Moran, Lisa J.
    Noakes, Manny
    Wittert, Gary A.
    Clifton, Peter M.
    Norman, Robert J.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2012, 25 (05) : 500 - 503
  • [8] Assesment of Inflammatory Markers and Epicardial Adipose Tissue Thickness in Women with Polycystic Ovary Syndrome
    Aslan, Gamze
    Aslan, Cagdas
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2019, 57 (04): : 349 - 355
  • [9] Elevation of markers of endotoxemia in women with polycystic ovary syndrome
    Banaszewska, Beata
    Siakowska, Martyna
    Chudzicka-Strugala, Izabela
    Chang, R. Jeffrey
    Pawelczyk, Leszek
    Zwozdziak, Barbara
    Spaczynski, Robert
    Duleba, Antoni J.
    [J]. HUMAN REPRODUCTION, 2020, 35 (10) : 2303 - 2311
  • [10] Serologic markers of autoimmunity in women with polycystic ovary syndrome
    Hefler-Frischmuth, Katrin
    Walch, Katharina
    Huebl, Wolfgang
    Baumuehlner, Konstantin
    Tempfer, Clemens
    Hefler, Lukas
    [J]. FERTILITY AND STERILITY, 2010, 93 (07) : 2291 - 2294